releases: https://emmer.house.gov/media-center/press-releases/icymi-effort-to-research-childhood-disease-passes-house

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url	title	date	year	month	party	chamber	state	member_name	bioguide_id	domain	scraper	source	date_source	text	has_text	collected_at	updated_at
https://emmer.house.gov/media-center/press-releases/icymi-effort-to-research-childhood-disease-passes-house	ICYMI: Effort to Research Childhood Disease Passes House	2022-08-16	2022	2022-08	Republican	House	MN	Tom Emmer	E000294	emmer.house.gov	emmer	https://emmer.house.gov/media-center/press-releases	scraper	Washington, D.C.— Congressman Tom Emmer (MN-06) announced the Gabriella Miller Kids First Research Act 2.0, which he cosponsored, has passed the House. The bill is named for Gabriella Miller, who tragically passed away in 2013 at the age of ten with an inoperable brain tumor. “As a father, the pain of losing a child is unimaginable. As someone who has lost a loved one to cancer, the need for further investment to find a cure remains a personal mission,” Emmer said. Emmer continued, “Thanks to advances in research, children suffering from cancer and other diseases have better outcomes than ever before. We must invest in this important research, and I was proud to be part of the effort to secure this necessary funding.” Background: In 2014, the Gabriella Miller Kids First Research Act was signed into law, establishing a pediatric research initiative through the National Institutes of Health. Since 2015, the Program has studied 44 childhood cancers and birth defects for genome sequencing, representing 28,000 patients and 48,000 genomes. The Gabriella Miller Kids First Research Act 2.0 would direct certain penalties assessed by the Securities and Exchange Commission to aid in the race to cure childhood cancer and other diseases. ###	1	2026-03-30T01:40:41Z	2026-04-08T02:59:24Z